Beam Therapeutics, Inc. (BEAM)
27.94
-1.59
(-5.38%)
USD |
NASDAQ |
May 15, 16:00
27.90
-0.04
(-0.14%)
After-Hours: 20:00
Beam Therapeutics EPS Diluted (Quarterly) : -0.9134 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8121 |
| Twist Bioscience Corp. | -0.7134 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| Anika Therapeutics, Inc. | -0.3737 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -94.32M |
| Revenue (Quarterly) | 31.74M |
| Total Expenses (Quarterly) | 126.06M |
| Enterprise Value | 2.077B |
| Gross Profit Margin (Quarterly) | 82.34% |
| Profit Margin (Quarterly) | -297.2% |
| Earnings Yield | -2.46% |
| Normalized Earnings Yield | -2.650 |